![]() MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. | Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. | Medicalsystem Biotechnology Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider. | Sysmex Inostics Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers. | Diater Diater is a pharmaceutical company specializing in the field of allergy treatment with immunotherapy. | |
Founding Date | Founding Date 1992 | Founding Date 1995 | Founding Date 2003 | Founding Date 2008 | Founding Date 1999 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Planegg, DE HQ Boston, US | Locations San Diego, US HQ | Locations Ningbo Shi, CN HQ | Locations Hamburg, DE HQ Kobe, JP Baltimore, US | Locations Barcelona, ES HQ |
Employees | Employees 464 | Employees 9735% increase | Employees 2,104 | Employees 65 | Employees 1644% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) €238.3m (FY, 2023) | Revenue (est.) $6.8m (FY, 2022) | Revenue (est.) ¥1.7b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods €34.6m (FY, 2023) | Cost of goods N/A | Cost of goods ¥966.1m (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €205.5m (FY, 2023) | Gross profit N/A | Gross profit ¥761m (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income (€189.7m) (FY, 2023) | Net income ($141.8m) (FY, 2022) | Net income ¥262.7m (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 126m | Total funding raised $ 130m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View companyMedicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.
View companySysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
View companyDiater is a pharmaceutical company specializing in the field of allergy treatment with immunotherapy.
View company